Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
CompletedOBSERVATIONAL
Enrollment
3
Participants
Timeline
Start Date
November 30, 2005
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Conditions
Breast Tumors
Trial Locations (1)
13210
SUNY Upstate Medical University, Syracuse
All Listed Sponsors
lead
State University of New York - Upstate Medical University
OTHER
NCT00639171 - Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant | Biotech Hunter | Biotech Hunter